Company Announcements Affymetrix has contributed genotyping data for a large set of validated rare and common genetic variants to the 1000 Genomes Project. It has also released a larger data set of approximately five million variants on its website. In January, Affymetrix signed a distribution agreement with Fisher Scientific for its GeneAtlas System and related […]
Waltham, MA 2/24/11; Madison, NJ 2/24/11; Paris, France 2/24/11—Thermo Fisher Scientific has agreed to sell two of its laboratory testing businesses (see IBO 1/15/11). The company will sell reference lab Athena Diagnostics to Quest Diagnostics for $740 million in cash. Athena Diagnostics had 2010 revenues of $110 million. Thermo will also sell contract testing lab […]
?tsu, Japan 2/15/11; New Delhi, India 2/15/11—Takara Bio will set up a joint venture with Indian distributor DSS Imagetech for the manufacture and sale of research reagents, kits and instruments. Takara Bio will hold a 51% stake in the new company, which will be named DSS Takara Bio. Takara Bio stated that its goal for […]
Billerica, MA 2/24/11—Bruker has entered into an agreement to acquire Michrom Bioresources, a provider of LC instrumentation, accessories and consumables. Financial details were not disclosed. Michrom recorded 2010 revenues of $3 million. “Michrom’s broad portfolio of novel technologies and high-performance products is highly complementary to our mass spectrometry products,” said Mr. Collin D’Silva, president of […]
Waltham, MA 2/14/11—PerkinElmer has acquired chemagen Biopolymer-Technologie AG, a provider of automated nucleic acid isolation technologies. “The addition of chemagen’s complementary products to PerkinElmer’s portfolio will provide the company with robust platforms and solutions to meet the needs of the rapidly evolving molecular diagnostics market,” stated Daniel R. Marshak, PhD, chief scientific officer and president […]
Santa Clara, CA 2/28/11—Agilent has acquired Lab901, a provider of electrophoresis equipment and consumables, for an undisclosed amount. Lab901 develops and markets the TapeStation benchtop electrophoresis instrument and Screen Tape consumables and reagents. “With the addition of Lab901’s outstanding technology and talented team, Agilent can now address customer needs across the entire span of electrophoresis […]
Japan’s total R&D expenditures declined for the second year in a row in fiscal 2010 (April 1, 2009–March 31, 2010). The country’s total R&D expenditures reached ¥17,246.3 billion ($185.4 billion = ¥93 = $1), a decrease of 8.3%. Total R&D expenditures as a percentage of GDP declined 0.18% to 3.62% in fiscal 2010. The figures […]
Thirteen of the 20 companies in the IBO Laboratory Sales Index reported fourth-quarter earnings before this issue’s publication. OI was removed following the acquisition by ITT in November (see IBO 9/15/10). Based on estimates for companies yet to report, fourth-quarter revenue for the Index improved 6.2%, including a loss of 0.2% from currency, to $5,912.9 […]
The excitement about and focus on genomic sequencing stems from the high sales growth and untapped potential of massively parallel sequencing technologies, or next-generation sequencing (NGS). The current generation of sequencers employs similar chemistries, yet utilizes unique strategies. Roche’s Genome Sequencer FLX and GS Junior systems use a combination of emulsion PCR, and sequence by […]
NanoString Technologies was founded in 2003 to develop a technology to detect and count large sets of target molecules in biological samples. Headquartered in Seattle, Washington, the company employs about 90 people and has raised more than $47 million since it was founded. NanoString Technologies launched its first commercial instrument, the nCounter Analysis System, in […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
